Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families

Abstract

The objective of this study was to evaluate apoptosis and production of IL-10 in SLE patients, their spouses and first-degree relatives in Icelandic SLE multicase families. Previously, increased IL-10 production has been found in all three groups. As IL-10 has been found to induce apoptosis in SLE, the percentage of lymphocytes undergoing apoptosis was evaluated, as well as the possible correlation between apoptosis and IL-10 production. Apoptosis and IL-10 production were studied in SLE patients (n = 12) from SLE multicase families and their spouses (n = 12) and a matched control group of healthy individuals(n = 10). The proportion of T and B lymphocytes undergoing apoptosis at 0, 24, 48 and 72 h was detected by flow cytometry using Annexin V and PI staining and the rate of apoptosis was calculated. IL-10 production was studied simultaneously by ELISpot analysis of freshly isolated peripheral blood mononuclear cells. In addition, T lymphocyte apoptosis at t = 0 was investigated in a group of non-household first-degree relatives (n = 10) and controls (n = 10). Antinuclear and antilymphocyte antibodies were analysed in all the groups. The SLE patients as a group had a significantly increased percentage of T lymphocytes in apoptosis at 0 and 48 h and a significantly higher number of IL-10 producing cells as compared with the healthy controls (P = 0.03, 0.02 and 0.03, respectively). The spouses also had significantly increased percentage of T lymphocytes in apoptosis (t = 0) and a significantly higher number of IL-10-producing cells when compared with healthy controls (P = 0.01 and 0.02, respectively). There were no significant differences between the patients and their spouses. For apoptosis of B lymphocytes no difference was found between the groups. The SLE patients as a group had the highest rate of apoptosis. No correlation between the degree and rate of apoptosis and the number of IL-10-producing cells was detected. The first-degree relatives did not have increased percentage of T lymphocytes undergoing apoptosis at t = 0 compared with healthy controls. The SLE patients had higher titres of ANA compared with the other groups. No correlation was detected between the ANA titre and the percentage of lymphocytes undergoing apoptosis. There was no correlation between disease activity as measured by SLEDAI and apoptosis. In conclusion, our results suggest that environmental factors common to both SLE patients and their spouses are associated both with the increased apoptosis and increased spontaneousproduction of IL-10, thus providing support for the notion that both environmental and genetic factors influencing apoptosis are of importance for the development of SLE.

Keywords

apoptosis first-degree relatives IL-10 production SLE SLE multicase families spouses

References

Emlen W , Niebur J , Kadera R . Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus . J Immunol 1994; 152: 3685–3692 .

Lorenz H-M , Grunke M , Hieronymus T , Herrmann M , Kuhnel A , Manger B , Kalden J . In vitro apoptosis and expression of apoptosisrelated molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases . Arthritis Rheum 1997; 40: 306–317 .

Perniok A , Wedekind F , Herrmann M , Specker C , Schneider M . High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus . Lupus 1998; 7: 113–118 .

Courtney P , Crockard A , Williamsson K , Irvine A , Kennedy R , Bell A . Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA and neutropenia . Ann Rheum Dis 1999; 58: 309–314 .

Mevorach D , Zhou J , Elkon K . Immunization of mice with apoptotic cells induces low levels of autoantibodies . (Abstract.) Arthritis Rheum 1996; 39(Suppl 9): S143-S143 .

Casciola-Rosen L , Anhalt G , Rosen A . Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes . J Exp Med 1994; 179: 1317–1330 .

Huggins M , Todd I , Cavers M , Pavuluri R , Tighe P , Powell R . Antibodies from systemic lupus erythematosus sera define differential release of autoantigens from cell lines undergoing apoptosis . Clin Exp Immunol 1999; 118: 322–328 .

Utz P , Anderson P . Posttranslational protein modification, apoptosis and the bypass of tolerance to autoantigens . Arthritis Rheum 1998; 41: 1152–1160 .

Courtney P , Crockard A , Williamson K , Mc Connell J , Kennedy R , Bell A . Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity . Lupus 1999; 8: 508–513 .

10.

Llorente L , Zou W , Levy Y , Richaud-Patin Y , Wijdenes J , Alcocer-Varela J , Morel-Fourrier B , Brouet J-C , Alarcon-Segovia D , Galanaud P , Emilie D . Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production in human systemic lupus erythematosus . J Exp Med 1995; 181: 839–844 .

11.

Llorente L , Richaud-Patin Y , Fior R , Alcocer-Varela J , Wijdenes J , Fourrier B , Galanaud P , Emilie D . In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus . Arthritis Rheum 1994; 37: 1647–1655 .

12.

Barcellini W , Rizzardi G , Borghi M , Nicoletti F , Fain C , Del Papa N , Meroni P . In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity . Lupus 1996; 5: 139–145 .

13.

Gröndal G , Gunnarsson I , Rönnelid J , Rogberg S , Klareskog L , Lundberg I . Cytokine production, serum levels and disease activity in systemic lupus erythematosus . Clin Exp Rheumatol 2000; 18: 565–570 .

14.

Georgescu L , Vakkalanka R , Elkon K , Crow M . Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand . J Clin Invest 1997; 100: 2622–2633 .

15.

Westendorp R , Langermans J , Huizinga T , Elouali A , Verweij C , Boomsma D , Vandenbroucke J . Genetic influence on cytokine production and fatal meningococcal disease . Lancet 1997; 349: 170–173 (published erratum appears in Lancet. 1997; 349: 656; see comments).

16.

Llorente L , Richaud-Patin Y , Couderc J , Alarcon-Segovia D , Ruiz-Soto R , Alcocer-Castillejos N , Alcocer-Varela J , Granados J , Bahena S , Galanaud P , Emilie D . Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1429–1435 .

17.

Gröndal G , Kristjansdottir H , Gunnlaugsdottir B , Arnason A , Lundberg I , Klareskog L , Steinsson K . Increased production of IL-10 in Icelandic SLE-patients, their first degree relatives and spouses in Icelandic multicase families . Arthritis Rheum 1999; 42: 1649–1654 .

18.

van der Linden M , Westendorp R , Sturk A , Bergman W , Huizinga T . High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus . J Invest Med 2000; 48: 327–334 .

19.

Miles S , Isenberg D . A review of serological abnormalities in relatives of SLE patients . Lupus 1993; 2: 145–150 .

20.

DeHoratius R , Messner R . Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus . J Clin Invest 1975; 55: 1254–1258 .

21.

Lehman T , Hanson V , Zvaifler N , Sharp G , Alspaugh M . Antibodies to nonhistone nuclear antigens and antilymphocyte antibodies among children and adults with systemic lupus erythematosus and their relatives . J Rheumatol 1984; 11: 644–647 .

22.

Williams W , Isenberg D . A cross-sectional study of anti-DNA anti-bodies in the serum and IgG and IgM fraction of healthy individuals, patients with systemic lupus erythematosus and their relatives . Lupus 1996; 5: 576–586 .

23.

Jones D , Hopkinson N , Powell R . Autoantibodies in pet dogs owned by patients with systemic lupus erythematosus . Lancet 1992; 339: 1378–1380 .

24.

Tan E , Cohen A , Fries J , Masi A , McShane D , Rothfield N , Schaller J , Talal N , Winchester R . The 1982 revised criteria for the classi-fication of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

25.

Bombardier C , Gladman D , Urowitz M , Caron D , Chang C . Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum 1992; 35: 630–640 .

26.

Rönnelid J , Klareskog L . A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes . J Immunol Meth 1997; 200: 17–26 .

27.

Vermes I , Haanen C , Steffens-Nakken H , Reutclingsperger C . A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V . J Immunol Meth 1995; 184: 39–51 .

28.

Kissmeyer-Nielsen F , Kjerbye K . Lymphocytotoxic micro-technique purification of lymphocytes by flotation. Histocompatibility Testing. 1967; 381–393.

29.

Okudaira K , Searles R , Tanimoto K , Horiuchi Y , Williams R . T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus . J Clin Invest 1982; 69: 1026–1038 .

30.

Burdin N , Péronne C . Epstein–Barr virus transformation induces B lymphocytes to produce human interleukin-10 . J Exp Med 1993; 177: 295–304 .

31.

Ullrich S . Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells . J Immunol 1994; 152: 3410–3415 .

32.

Herrmann M , Voll R , Zoller O , Hagenhofer M , Ponner B , Kalden J . Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus . Arthritis Rheum 1998; 41: 1241–1250 .

33.

Sturfelt G , Klint C , Andreasson A , Johansson I , Truedsson L . Effect of complement and immune complexes in the induction of apoptosis in SLE. (Abstract.) Arthritis Rheum. 1998; abstract no. 247-247.

34.

Sturfelt G , Bengtsson A , Klint C , Nived O , Sjöholm A , Truedsson L . Novel roles of complement in systemic lupus erythematosus—hypothesis for a pathogenetic vicious circle . J Rheumatol 2000; 27: 661–663 .